Rep. Greg Landsman Sells Off Shares of Danaher Co. (NYSE:DHR)

Representative Greg Landsman (D-Ohio) recently sold shares of Danaher Co. NYSE: DHR. In a filing disclosed on April 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in Danaher stock on March 27th. The trade occurred in the Representative's "SARAH LANDSMAN TRADITIONAL IRA" account.

Representative Greg Landsman also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of CrowdStrike NASDAQ: CRWD on 3/27/2025.
• Sold $1,001 - $15,000 in shares of Cadence Design Systems NASDAQ: CDNS on 3/27/2025.
• Sold $15,001 - $50,000 in shares of Simon Property Group NYSE: SPG on 3/27/2025.
• Sold $1,001 - $15,000 in shares of L3Harris Technologies NYSE: LHX on 3/27/2025.
• Sold $15,001 - $50,000 in shares of Visa NYSE: V on 3/27/2025.
• Sold $15,001 - $50,000 in shares of Cencora NYSE: COR on 3/27/2025.
• Sold $15,001 - $50,000 in shares of Alphabet NASDAQ: GOOGL on 3/27/2025.
• Sold $1,001 - $15,000 in shares of Ameriprise Financial NYSE: AMP on 3/27/2025.
• Sold $15,001 - $50,000 in shares of Salesforce NYSE: CRM on 3/27/2025.
• Sold $1,001 - $15,000 in shares of Equinix NASDAQ: EQIX on 3/27/2025.

Danaher Price Performance

Shares of DHR traded up $3.01 during mid-day trading on Monday, hitting $191.74. 1,717,700 shares of the company traded hands, compared to its average volume of 3,313,305. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $137.04 billion, a price-to-earnings ratio of 36.31, a PEG ratio of 2.66 and a beta of 0.86. The business has a 50-day moving average of $203.71 and a 200 day moving average of $229.58. Danaher Co. has a one year low of $171.00 and a one year high of $281.70.

Remove Ads

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the company posted $2.09 earnings per share. As a group, equities analysts expect that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.67%. The ex-dividend date of this dividend is Friday, March 28th. This is a boost from Danaher's previous quarterly dividend of $0.27. Danaher's dividend payout ratio (DPR) is presently 24.24%.

Insider Buying and Selling

In other news, SVP Brian W. Ellis sold 5,700 shares of the company's stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. 11.10% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Danaher

Several hedge funds have recently made changes to their positions in DHR. Heck Capital Advisors LLC acquired a new position in Danaher during the fourth quarter worth $27,000. Decker Retirement Planning Inc. bought a new stake in Danaher during the 4th quarter worth about $31,000. Golden State Wealth Management LLC acquired a new position in shares of Danaher during the 4th quarter worth about $31,000. Hurley Capital LLC bought a new position in shares of Danaher in the 4th quarter valued at about $34,000. Finally, Pineridge Advisors LLC increased its position in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock valued at $34,000 after acquiring an additional 57 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on DHR shares. The Goldman Sachs Group raised shares of Danaher from a "neutral" rating to a "buy" rating and set a $260.00 target price on the stock in a research note on Friday, March 21st. Scotiabank assumed coverage on shares of Danaher in a research report on Monday, December 23rd. They set a "sector perform" rating and a $265.00 target price for the company. Royal Bank of Canada restated an "outperform" rating and issued a $277.00 price target (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Jefferies Financial Group dropped their price objective on Danaher from $285.00 to $260.00 and set a "buy" rating for the company in a report on Wednesday, January 29th. Finally, JPMorgan Chase & Co. reduced their target price on Danaher from $310.00 to $300.00 and set an "overweight" rating on the stock in a report on Tuesday, January 28th. Four analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company's stock. According to MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and a consensus target price of $276.57.

About Representative Landsman

Greg Landsman (Democratic Party) is a member of the U.S. House, representing Ohio's 1st Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027. Landsman (Democratic Party) is running for re-election to the U.S. House to represent Ohio's 1st Congressional District. He declared candidacy for the 2026 election. Greg Landsman was born in Cincinnati, Ohio, and lives in Mt. Washington, Ohio. Landsman earned a B.A. in economics and political science from Ohio University and an M.A. in theological studies, religion, and public policy from Harvard University in 2004. His career experience includes working as the executive director of The Strive Partnership with the KnowledgeWorks Foundation and the director of the Ohio Governor's Office of Faith-Based and Community Initiatives.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.